Skip to main content
Log in

High incidence of ADRs in COVID-19 patients in China

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Sun J, et al. Incidence of Adverse Drug Reactions in COVID-19 patients in China: an active monitoring study by Hospital Pharmacovigilance System. Clinical Pharmacology and Therapeutics : 23 Apr 2020. Available from: URL: http://doi.org/10.1002/cpt.1866

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

High incidence of ADRs in COVID-19 patients in China. Reactions Weekly 1802, 7 (2020). https://doi.org/10.1007/s40278-020-77925-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-77925-x

Navigation